On June 24, Melanoma Research Alliance’s (MRA) Chief Science Officer Marc Hurlbert and Director of Communications Cody Barnett joined Antidote's Head of Partnerships Lindsey Wahlstrom-Edwards in a webinar to discuss what matters most to melanoma patients when it comes to participating in clinical trials. The conversation, informed by a 2018 study of 444 melanoma patients and survivors, provided ...
Continue reading